Podcasts about CSO

In this episode of Deciphered, Mike Cashman, partner, Bain & Company is joined by Ricardo Correia, partner, Bain & Company, Dante Disparte, CSO and Head of Global Policy and Operations, Circle, Jane McEvoy, SVP Fintech, BVNK and Cindy Turner, Chief Product Officer, WorldPay to discuss the state of stablecoins in 2025.Timestamps:03:22 Stablecoin infrastructure providers and enterprise integration04:53 WorldPay's stablecoin payout solutions for marketplaces06:11 Stablecoins disrupting traditional cross-border payments10:00 Singleness of money and stablecoin interoperability14:40 Elasticity of money and stablecoin reserves17:41 Productization of stablecoins in payouts and escrow27:03 Regulatory harmonization for stablecoins across jurisdictions31:27 Future use cases of stablecoins beyond cross-border paymentsPlease subscribe to the show so you never miss an episode, and leave us a review if you enjoy the show!You can find Mike Cashman hereYou can find Ricardo Correia hereYou can find Dante Disparte hereYou can find Jane McEvoy hereYou can find Cindy Turner hereFor more insights from the Deciphered podcast, visit the page on Bain's website

Dr. Brendan O'Shea, Kildare GP, Medical Director at K Doc, and Assistant Professor of Primary Care at Trinity College Dublin & Jen Hogan, Columnist with the Irish Times join Tom Dunne to discuss the latest CSO report on children's health, which highlights strong overall health among Irish children, but also raises concerns about dental care and access to services.

Built to last.That's not just a slogan — it's a strategy.In an industry driven by short-term survival, the cannabis space often feels like a rollercoaster. Financial pressures and market volatility push companies to chase quarters instead of building moats.But what if you could play the long game?What if you could invest in domain knowledge, develop key expertise, and build durable competitive advantages across the supply chain?Organigram is doing exactly that.With financial backing from British American Tobacco (BAT), Organigram is executing a strategy rooted in sustainability — not hype. It's a deliberate, disciplined approach designed to capitalize on where the industry is going, not just where it is today.This week on The Dime, we sit down with Paolo De Luca, CSO of Organigram, to explore:BAT collaborative product developmentM&A strategy — and what they're eyeing nextCompetitive advantage: where Organigram is building across cannabis verticals Chapters00:00 Introduction to Organigram and Paolo De Luca02:03 Organigram's Business Model and Market Position05:13 International Expansion and EUGMP Certification10:12 Navigating Market Dynamics and Data Challenges15:05 Learning from the US Cannabis Market18:11 Future Prospects and Strategic Focus Areas24:04 Integration of Acquisitions and Operational Synergies28:10 Integrating Expertise for Operational Efficiency30:16 Navigating the Relationship with BAT33:27 Leveraging Competitive Advantages in Cannabis39:12 Exploring AI in Cannabis Operations41:47 Innovations in Seed-Based Cultivation44:55 Cross-Industry Insights for Cannabis Efficiency50:01 The Path to a Stable Cannabis Market52:38 Lessons from Financial History53:38 Defining Long-Term Competitive Advantages  SummaryIn this episode, Bryan Fields and Kellan Finney interview Paolo De Luca, Chief Strategy Officer of Organigram, discussing the company's strategic approach to building a sustainable cannabis business. They explore Organigram's market position, international expansion efforts, the importance of EUGMP certification, and the challenges of data transparency in the cannabis industry. Paolo shares insights on the rise of cannabis beverages, the significance of M&A strategies, and the innovative shift towards seed-based cultivation. The conversation also touches on the collaboration with BAT and the potential role of AI in cannabis operations, concluding with thoughts on the future of the cannabis market and the importance of long-term competitive advantages.Guest Links:https://www.linkedin.com/in/paolo-deluca/https://www.organigram.ca/https://x.com/Organigram_Inchttps://www.linkedin.com/company/organigram/Our Links Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterAt Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.Sign up for our playbook here:

This week, AmSpa founder and CEO Alex R. Thiersch, JD, sits down with Chris Suchánek, founder and CSO of Firm Media and creator of Ailm Atelier, a new online platform showcasing aesthetic doctors and their stories. They talk about Chris's journey from the music business to specialty medical marketing, and how authenticity, storytelling, and innovation are reshaping how med spas and aesthetic practices connect with patients. How he transitioned from Grammy-winning music marketing to aesthetic advertising; The origin and mission of Ailm Atelier as a platform for storytelling and recognition; Why authenticity and patient trust are the new currency in aesthetic branding; The nomination-only process for Ailm's featured top aesthetic doctors; How he redefined his personal brand with inspiration from a 90s billboard campaign; A mixed media marketing approach to target med spa patients in their homes; The future of Ailm as a consumer-facing, digital platform. — Music by Ghost Score

What does it take to stay calm in the face of constant cyber pressure—and why does that mindset matter more than ever? In this episode of Security Matters, host David Puner speaks with Den Jones, founder and CEO of 909Cyber, about his transition from enterprise chief security officer (CSO) to cybersecurity consultant. They explore what it means to lead with clarity and composure in a high-stakes environment, the realities of launching a firm in a crowded market, and how pragmatic security strategies—especially around identity, AI, and Zero Trust—can help organizations navigate AI-driven threats, talent shortages, and operational complexity. It's a candid conversation about what works and what doesn't when it comes to modern security leadership.

In this episode, Mark Ledlow is joined by Benjamin Whitfield, a seasoned security professional with a military and agency background and a former CIA. They discuss Ben's transition from being an executive in Silicon Valley to an independent consultant, and delve into the complexities of the security industry. Key topics include the role of Chief Security Officers, the importance of sales in security, and the need for risk-based assessment. They also explore emerging trends in security, the impact of the new administration, and the importance of continuing education for security professionals.Learn about all this and more in this episode of The Fearless Mindset Podcast.KEY TAKEAWAYSBuilding relationships is crucial for ensuring security programs are funded and supported. The role of a Chief Security Officer (CSO) involves significant political and sales skills. Proper risk assessments tailored to the company culture are essential for effective security programs. The executive protection industry's future might see growth due to increasing threats and new economic sectors like cryptocurrency. Ongoing education and adaptation to emerging trends and technologies are vital for security professionals.QUOTES"It's all sales... Your job really is to advocate for how do you protect people, facilities, operations as much as possible given what the political climate is in your company." "If you build a program that meets the absolute corporate need, your job isn't going away." "In Silicon Valley, I'll stereotype. I'm just the kid wearing the hoodie. You're the kid wearing the hoodie who's now worth, you know, a billion dollars." "There are multiple ways where a company can provide, can have security for its senior most executives." "The CSO chair is, you're playing politics, you're fighting for budget with everybody else."Get to know more about Benjamin Whitfield through the links below.https://www.linkedin.com/in/benjaminwhitfield/To hear more episodes of The Fearless Mindset podcast, you can go to https://the-fearless-mindset.simplecast.com/ or listen to major podcasting platforms such as Apple, Google Podcasts, Spotify, etc. You can also subscribe to the Fearless Mindset YouTube Channel to watch episodes on video.

Sensory analysis, setting up a lab for QC tests, and understanding your raw ingredients are all paramount when it comes to improving the quality of your beer. We talk with two experts - Lindsay Barr and Ashton Lewis - who are here to help you level up beer quality in a small-scale brewery.Guests:Lindsay Barr is the CSO and Founding Partner of DraughtLab Sensory Software where she helps food & beverage companies use tasting technology to make products that people love.  After earning a Masters in Food Science from UC Davis, she began her career at New Belgium Brewing Company managing the Sensory and Consumer Research program. Along with her work at DraughtLab, she teaches Sensory for the Master Brewers course at UC Davis and the Siebel Institute and judges global beer competitions. During her career, she has published numerous groundbreaking techniques to lower the barrier-to-entry into sensory science and continues to be passionate about making sensory accessible for all businesses. She currently lives in San Francisco and can be found running or lounging in Golden Gate Park, sailing, or playing around in the Castro.For the last 29 years Ashton Lewis has worked for Brew Your Own Magazine as technical editor and “Help Me, Mr. Wizard” columnist.  His day job since December 2016 has been with RahrBSG where he is currently Manager of Training and Technical Support.  Prior to working in the world of ingredients, Ashton was the Staff Master Brewer and Brewing Group Sales Manager for the Paul Mueller Company living in the world of custom stainless steel.  He was also a partner in the Springfield Brewing Company (SBC) in Springfield, Missouri, and SBC's master brewer from 1997 to 2019.  Ashton holds a B.S. in Food Science from Virginia Tech (1991) and a M.S. in Food/Brewing Science from UC Davis (1994), and is currently the MBAA District Great Plains Technical Chair.  In his spare time, he enjoys music, cooking, homebrewing, talking about beer, and playing with Excel. The BYO Nano Podcast Episode 67  is sponsored by:Five Star ChemicalsLooking for a powerful, no-rinse sanitizer that gets the job done fast? Meet Saniclean PAA Pro from Five Star Chemicals. This EPA-registered, PAA-based acid sanitizer is tough on beerstone and perfect for everything from kegs to packaging lines. Available in two convenient sizes, it's ideal for coarse sprayers, fermenters, and more. Trusted by pros, designed for performance—Saniclean PAA Pro helps you brew with confidence. Learn more at fivestarchemicals.com. Brew better. Brew with Five Star.FermentisWanna brew a Lager? Discover the whole SafLager™ range by Fermentis. Whether you're looking for floral, fruity, or even estery notes, Fermentis has your back! Want to know more about Fermentis yeasts? Visit www.fermentis.com! BYO Nano+ MembershipGet access to hundreds of hours of on-demand videos covering small craft brewery strategies with BYO's Nano+ Membership. Learn from craft beer experts watching replays of past NanoCon seminars plus a complete library of in-depth workshops. You'll also have full online access to all of BYO's digital content and an annual digital magazine subscription. Check out byo.com/nanoplus for more details.BYO Nano Brew Podcast Episode 67Host: John HollGuests: Lindsay Barr, Ashton LewisContact: nano@byo.comMusic: Scott McCampbell

„Wir haben Rauchen sexy gemacht. Wir haben den Diamanten am Ehering zum ultimativen Liebesbeweis inszeniert. Marketing hat Lebensstile geprägt wie kaum etwas anderes. Warum tun wir uns so schwer, CO₂-Reduktion genauso begehrenswert zu erzählen?“, plädiert Birgit Berthold-Kremser. Marketing hat diese Macht. Und genau darin liegt aber auch das Dilemma: Statt Märkte und Gesellschaft mutig zu gestalten, zieht sich die Branche oft zurück und wird zusehends darauf reduziert, hübsche Weißräume auszumalen. ‚Wir sitzen auf einem Innovationsmotor. Es wäre doch absurd, den nicht zu nutzen‘, sagt Stefanie Kuhnhen. In dieser Folge von #WhatsNextAgencies spricht Kim Alexandra Notz mit Birgit Berthold-Kremser, CMO & Sustainability Executive, und Stefanie Kuhnhen, CSO, Serviceplan Germany, über eine Branche zwischen Greenwashing, Greenhushing und großen Purpose-Claims, denen häufig der Mut zur echten Verantwortung fehlt. Die beiden machen klar: Marketing war schon immer mehr als Kommunikation. Auch Nachhaltigkeit ist daher kein weiches Image-Thema, sondern ein ganzheitlicher Wirtschaftsfaktor, den die Märkte ganheitlich einbeziehen müssen: Neben der Promotion auch bei Produkt, Preis und Place. Und gemäß ihres 4x4 Superpower Modells auch in Leadership Principles, Purpose-Findung und Print-Bestimmung mit einfließen muss. Dabei zeigt sich oft, dass kleine Hebel deutlich wirkungsvoller sein können als große Budgets. Schon nachhaltige Produkte an der Kasse können Kaufverhalten und Produktionsprozesse maßgeblich verändern. Trotzdem bleiben viele Marketingverantwortliche zögerlich. Wenig Fachwissen, Angst vor Komplexität, das bequeme Festhalten am ‚Weiter so‘ und eine Branche, die sich häufig treiben lässt, verhindern, dass Marketing seine Rolle als echter Steuerungshebel wahrnimmt. Und damit ein strategisches Zukunftsthema in jedem Unternehmen bedient! Genau hier liegt jedoch die Chance: Marketing kann sich neu erfinden, damit neue Relevanz in Vorstandsräumen gewinnen und wieder zum Instrument werden, das Märkte aktiv gestaltet. Dazu braucht es auch Agenturpartner, die unbequeme, aber zukunftsweisende Fragen stellen, um die Marke zukunftssicher zu machen. Für alle, die ernsthaft einsteigen wollen, bietet das Gespräch konkrete Ansätze: Zertifikate, die Agenturen jetzt wirklich prüfen sollten: ISO 14001, EcoVadis, STBI, Global Compact, ISO 27001 (IT-Security), ISO 9001 (PM-Qualität). Das Buch: „Superpower Sustainable Marketing“ von Kuhnhen, Berthold-Kremser & Mozart. Alle Leitfragen & KPIs zum 4x4-Framework: marketing-superpower.com

The CSO's Irish Health Survey for 2024 has found that 56% of people aged 55-64 drink alcohol at least weekly compared to just 27% of 18–24-year-olds. But what is driving this trend, and what are the broader health implications? Joining Sean Defoe to discuss is Dr Sheila Gilheany, CEO of Alcohol Action Ireland.

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Hella Kohlhof, CSO at Immunic. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Hella, covering: How the 'waste of two molecules' led to the spin-out creation of Immunic Therapeutics. The perfect blend of a founding team willing to split responsibility, learn and have a go. Ending up as a Nasdaq-listed company via a reverse merger... and all the new challenges that came with it. Immunic's divide-and-conquer global outsourcing strategy, while retaining tight control. Examples of how geopolitical issues have impacted a biotech's growth. Hella leads the Immunic's scientific strategy, including mode of action research, preclinical studies, and biomarker development. Dr. Kohlhof brings deep expertise in immunology, oncology, and drug development, with previous roles at 4SC AG, where she led preclinical and clinical projects. She holds a doctorate in biology from Ludwig Maximilians University of Munich and completed her postdoc at the Helmholtz Centre, focusing on B cell development. She holds several patents, has co-authored numerous publications, and is a regular speaker at scientific and industry events. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

For years, disease diagnosis and treatment have focused on a few biomarkers, overlooking thousands of vital biological signals. Despite biotech advances, most therapies are still based on limited data, missing countless breakthroughs.Multiomics changes that. By analyzing tens of thousands of proteins, metabolites, and lipids, it reveals hidden insights, paving the way for smarter, faster, and more effective medical discoveries.In this must-listen episode, David Brühlmann welcomes Mo Jain, founder and CSO of Sapient, a pioneering force in bringing multiomic platforms out of academia and into the heart of drug development. A physician-scientist by training and a visionary entrepreneur by choice, Mo's journey spans decades at the cutting edge of analytical technologies, culminating in the creation of ultra-high-throughput systems that analyze up to 20,000 biomarkers in a single run for real-world impact.Here are three reasons why this episode needs to be on your playlist:Multiomics at Scale: Mo shares how his team at Sapient turbocharged mass spectrometry, enabling simultaneous measurement of thousands of molecules, transforming routine diagnostics and making previously unimaginable insights accessible to scientists everywhere.Turning Data into Action: Generating vast data is only half the battle. Mo explains how Sapient developed advanced biocomputational teams and frameworks to extract actionable answers, guiding drug developers to faster, smarter decisions and helping avoid the pitfalls that cripple so many omics projects.The Future Is Personalized and Sooner Than You Think: From dramatically earlier disease detection to truly personalized therapies, Mo paints an optimistic picture of a coming era where AI, multiomics, and new therapeutic modalities rapidly accelerate both discovery and delivery, reshaping how biotech companies tackle even the toughest diseases.Ready to break out of the 20-biomarker rut and see what 20,000 data points can reveal? Tune in to discover how you can harness multiomics in your own research and hear Mo's advice for scientists and entrepreneurs venturing beyond the bench.Connect with Mo Jain:LinkedIn: www.linkedin.com/in/mo-jain-md-phd-373895baWebsite: www.sapient.bioCompany LinkedIn Page: https://www.linkedin.com/company/sapientbioNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotechSupport the show

This discussion focuses on how mRNA and self-replicating RNA (srRNA) technologies are expanding far beyond COVID vaccines into revolutionary therapeutic applications for cancer and rare diseases. It is clear that mRNA therapeutics offer three major application areas: infectious disease vaccines, therapeutic vaccines for oncology, and protein replacement for monogenic rare diseases.Today's episode is sponsored by Eclipsebio. From AI-ready datasets to sequencing validation, they drive RNA success. Explore their solutions at https://eclipsebio.com/.Host⁠⁠⁠⁠⁠Lori Ellis⁠⁠⁠⁠⁠, Head of Insights, BioSpaceGuestsAndy Geall, Co-founder and Chief Development Officer, Replicate Bioscience; Chair of the Board, Alliance for mRNA MedicinesPad Chivukula, Co-founder, CSO & COO, Arcturus TherapeuticsDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

What if the secret to truly personalized precision medicine lies not in your genetic code, but in your zip code?For years, biotech has focused on genomics to explain disease and drug response, but DNA only accounts for a fraction of the story. The real breakthrough? Multi-omics: the large-scale analysis of proteins, metabolites, and lipids, powered by advanced mass spectrometry and AI, offering a fuller picture of human health.In this episode, David Brühlmann meets Mo Jain, founder and CSO of Sapient, a leader in multi-omics analytics. With over two decades of experience across physiology, biomedicine, and computational biology, Mo has been at the forefront of developing scalable multi-omics technologies that are changing the way we predict, diagnose, and treat disease. From leading an academic lab to building a pioneering biotech company, Mo's journey reflects a passion for uncovering the hidden 80–90% of disease risk that lies beyond our genes.Here are three reasons you'll want to listen to this episode:Your Environment Matters More Than Your Genes: Mo explains why your zip code is a stronger predictor of your health than your genetic code, challenging the industry's long-held beliefs and opening new avenues for disease prevention and risk assessment.Multi-omics Disrupts Drug Development: Discover how integrating thousands of biological data points can revolutionize drug discovery by identifying novel targets, better predicting drug response, and accelerating therapeutic breakthroughs that were previously out of reach.Big Data Finally Becomes Actionable: Thanks to rapid advances in mass spectrometry and computational power, scientists can now make sense of overwhelming volumes of multi-omic data, turning what was once information overload into actionable insights for diagnostics and drug development.Ready to think beyond your genes? The biotech revolution is here, and it starts in your neighborhood.Connect with Mo Jain:LinkedIn: www.linkedin.com/in/mo-jain-md-phd-373895baWebsite: www.sapient.bioCompany LinkedIn Page: https://www.linkedin.com/company/sapientbioNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotechSupport the show

Salonen & Apkalna - Broadcast by CSO Association

We are in the middle of the summer season. Dublin & Cork Airports have never been as busy but much of that are Irish citizens going abroad on holidays. What about the people coming to this country and the visitor attractions that they wish to see? The CSO says that visitor numbers are down 10% year on year. But the Tourism authorities dispute some of the data. So what is going on with our visitor attractions? Catherine Flanagan the chief executive of AVEA visitor attractions body discussed all with Joe this morning.

Breaking into Cybersecurity: Career Journey and Insights with Gavin Reid, CSO at Human SecurityIn this episode of Breaking into Cybersecurity, we are joined by Gavin Reid, Chief Security Officer at Human Security. Gavin shares his extensive career journey from NASA to leading cybersecurity teams at Cisco and Recorded Future, now part of MasterCard. He offers invaluable advice for those seeking to transition from technical roles into leadership positions within cybersecurity. The discussion covers evolving cybersecurity threats, the importance of continuous learning, and how to enable businesses to grow securely. Gavin also discusses the role of threat intelligence, the impact of AI on cybersecurity, and his approach to building effective security teams. Don't miss this insightful conversation on navigating the dynamic world of cybersecurity.00:00 Introduction and Guest Overview00:57 Gavin's Career Journey01:40 Transitioning from Technical to Leadership Roles03:04 Adapting to Industry Changes04:45 Security as a Business Enabler05:17 Navigating Security in Startups06:07 Vendor Perspective and Customer Support07:14 Threat Intelligence Integration11:27 Career Advice for Aspiring Threat Intelligence Analysts15:19 The Role of AI in Cybersecurity18:24 Final Thoughts and Human Security's Mission21:27 Conclusion

In this special episode of the MM+M Podcast, we sit down with Dr. Osama Hashmi — dermatologist, cofounder and chief product officer at Impiricus — alongside practicing physician Dr. Bilal Ahmed — an interventional/structural cardiologist, cofounder and CSO of Lylah, a personalized microbiome therapeutics company — to explore how artificial intelligence is transforming the way healthcare professionals connect with pharmaceutical resources. We'll dive into how Impiricus and the life science companies it works with are building and leveraging the first and only AI-powered field force enhancement tool designed to streamline real-time communication between HCPs and pharma reps. From clinical decision support to on-demand access to drug information, this conversation unpacks how technology can bridge long-standing gaps in care delivery and engagement.Tune in for a forward-looking discussion on the evolving needs of clinicians, the role of AI in healthcare and how pharma can better support providers in delivering optimal patient outcomes.  Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Two Enterprise Ireland-backed companies have won funding approvals of up to €18.75m in the latest competition under Horizon Europe's European Innovation Council (EIC) Accelerator Programme. The two successful companies are CroíValve and Lios. Enterprise Ireland leads the National Support Network for Horizon Europe which helps entrepreneurs to compete and win funding in EIC competitions. To date, 28 Irish companies have secured approvals totalling €175.5m under the EIC Accelerator Programme since the beginning of Horizon Europe in 2021. Trinity College Dublin spin-out company CroíValve is a clinical-stage medical device company focused on developing a minimally invasive device for the treatment of a severe cardiac disease called tricuspid regurgitation. CroíValve's DUO Tricuspid Coaptation Valve system will enable a non-surgical solution for the condition as currently less than one percent of elderly patients receive surgical treatment due to the risks involved in this population. CroíValve previously received funding under the Disruptive Technologies Innovation Fund which is administered by Enterprise Ireland and supports research collaboration to drive disruptive technology development. Lios, a pioneer in acoustic advanced materials technology, is a Dublin company with strong Sligo roots. SoundBounce is an advanced acoustic material developed by Lios that works better than traditional sound dampening materials. Transport, home appliances, power generation, and construction are among the major industries seeking to reduce noise levels. Part of the EU's Horizon Europe 2021-2027 Research and Innovation Programme, the EIC Accelerator Programme provides transformational funding to high-potential, high-risk start-ups, scale-ups and SMEs. Approvals include grant funding of up to €2.5 million combined with an equity investment ranging from €0.5 to €10 million in a blended finance offer. 959 applications were submitted to this latest competition with 150 companies subsequently selected for interview resulting in a total of 40 funding awards to 16 countries. The 40 companies were allocated funding of up to €229m in a combination of grants and equity investments. Almost one third of the selected companies were led by a woman in a key leadership role such as CEO, CTO or CSO. Minister of State for Trade Promotion, AI and Digital Transformation Niamh Smyth TD said: "Today's announcement is testament to the research and innovation capability of Irish companies and the vibrancy of the start-up and commercialisation eco-system. Collaboration between Higher Education, state agencies, investors, and business creates a pathway to success, and the government, through Enterprise Ireland, is committed to helping enterprises like Lios and CroíValve to realise their commercial potential. This announcement provides significant funding to support these companies to bring their innovations to the global market, and I wish both every success for the future." Jenny Melia, CEO Designate, Enterprise Ireland, said: "I'd like to congratulate Lios and CroíValve on their successful applications to the highly competitive EIC Accelerator programme. Both companies, working with the EIC, will be able to enhance their entrepreneurial capability and get the critical support required at this juncture in their development and scaling journey. It is particularly welcome to see that both projects have a female-inclusive leadership team which supports Enterprise Ireland's strategic ambition to increase the participation of women in entrepreneurship and business leadership." Lucy O'Keeffe, Co-Founder & CEO, CroíValve said: "Securing European Innovation Council (EIC) funding is very impactful in supporting full alignment of our novel technology with this complex patient population, along with expansion of clinical validation of our DUO System. There is a real unmet clinical need to provide a scalable treatment option for the heterogeneous patient population with tricuspi...

What happens when you're staring down the darkest moment of your life—and instead of breaking, you rise? In this powerful episode, Robert sits down with Kevin Palmieri, the CSO, Founder, and Host of Next Level University, a Top 100 Global Self-Improvement Podcast with over 2,000 episodes and listeners in 175+ countries.Kevin opens up about the day he nearly ended it all—and how that breaking point became his breakthrough. With brutal honesty and heart-driven purpose, he shares how he went all in on his mission to help others grow through holistic, no-BS self-improvement. Whether you're on the edge of change or looking for a sign to go after your dream, this conversation will shake you awake and fuel your next move.

As complexity in pharmaceutical development reaches new heights — especially with over 60% of recent FDA novel molecular entities falling outside traditional drug design rules — the need for advanced formulation and manufacturing strategies has never been greater. Precision medicine is no longer a future goal; it's a present necessity. And that's exactly where AustinPx comes in.At the forefront of this shift is AustinPx's KinetiSol technology, a powerful platform designed to make the “undevelopable” developable — transforming poorly soluble, highly potent small molecules into scalable, patient-ready therapies. Dr. Dave Miller, CSO, has spent more than 20 years in pharmaceutical R&D, helping drug developers navigate the challenges of bioavailability, permeability, and manufacturability for complex molecules.Today, we'll explore with Dave how CDMOs like AustinPx are empowering a new era of personalized treatment—while offering product protection strategies that help biopharma companies stand out in a competitive, cost-sensitive market. Qualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez

Comparing and contrasting “The Prince of Egypt” by Dreamworks Animation with scriptures from The Torah, The Holy Bible, and the Qur'an.  This podcast contains certain copyrighted works that were not specifically authorized to be used by the copyright holder(s), but which we believe in good faith are protected by federal law and the fair use doctrine (Section […] The post CSO 19c – The Prince of Egypt Part 3 first appeared on Cinema Story Origins Podcast.

Unlocking Influencer Marketing: A Conversation with Adam Rivietz of #PaidIn a recent episode of The Thoughtful Entrepreneur, host Josh Elledge speaks with Adam Rivietz, CSO and Co-Founder of #Paid, a platform revolutionizing influencer marketing by connecting brands with vetted creators. Adam shares how influencer marketing has evolved, the top challenges brands face, and how to approach creator partnerships more strategically.Navigating the Influencer Marketing LandscapeAdam opens the episode by reflecting on his personal journey, including how he overcame a fear of public speaking through stand-up comedy. This experience, he explains, mirrors the importance of authenticity—a key component in successful influencer marketing. Adam emphasizes that storytelling and genuine experiences resonate deeply, both on stage and in branded content.He goes on to describe the early skepticism brands had toward influencer marketing in 2014, and how platforms like #Paid have helped shift that perception. Today, brands recognize the value of creator-driven campaigns that feel native and personal. Adam discusses how declining organic reach, the rising cost of ads, and content fatigue are major challenges marketers face.#Paid addresses these issues by connecting brands with vetted creators who deliver authentic content and better engagement. The platform also enables creator licensing, allowing brands to run ads through influencers' accounts—boosting trust and conversion rates. Adam notes that enterprise brands and agencies, particularly those with mature digital strategies, benefit most from using #Paid.About Adam Rivietz:Adam Rivietz is the Chief Strategy Officer and Co-Founder of #Paid. He leads the company's strategic direction and is passionate about helping brands scale through authentic creator partnerships.About #Paid:#Paid is a creator marketing platform designed to help enterprise brands and agencies manage influencer campaigns at scale. With a focus on authenticity, #Paid offers tools for creator discovery, campaign execution, and paid media integration.Links Mentioned in this Episode:Adam Rivietz on LinkedIn#Paid Official WebsiteEpisode Highlights:Adam's personal growth journey from public speaking fear to stand-up comedy.The evolution and current state of influencer marketing.How #Paid helps brands overcome content, reach, and advertising challenges.The role of authenticity and creator licensing in successful campaigns.Why enterprise brands and agencies benefit most from #Paid's offerings.ConclusionJosh and Adam highlight a clear truth: authentic, creator-led campaigns are the future of digital marketing. Platforms like #Paid empower brands and agencies to scale these efforts effectively. Whether you're new to influencer marketing or looking to optimize your strategy, building real relationships with creators is the key to driving meaningful results.Apply to be a Guest on The Thoughtful Entrepreneur: https://go.upmyinfluence.com/podcast-guestMore from UpMyInfluence:We are actively booking guests for our The Thoughtful Entrepreneur. Schedule HERE.Are you a 6-figure consultant? I've got high-level intros for...

All links and images can be found on CISO Series. Check out this post for the discussion that is the basis of our conversation on this week's episode co-hosted by David Spark, the producer of CISO Series, and Mike Johnson, CISO, Rivian. Joining is Hanan Szwarcbord, vp, CSO and head of infrastructure, Micron Technology. In this episode Embracing growth An urgent need for creativity Get the business context Embrace your inner theater kid Huge thanks to our sponsor, Query.ai Query is a Federated Search and Analytics platform that builds a security data mesh, giving security teams real-time context from all connected sources. Analysts move faster and make better decisions with AI agents and copilots that handle the grunt work and guide each step. Learn more at query.ai

Guest post by Elisabeth Kant (she/her) Head of Data Science at SumUp Following the AI summit in Paris earlier this year, Taoiseach Micheál Martin stated "we need to embrace the opportunities that AI offers - for our start-ups and businesses, our public services, and ultimately for our citizens, and their quality of life.…If we don't, we risk losing out and forfeiting the enormous gains AI promises." In an increasingly digital world, small and medium-sized enterprises face a pivotal moment: adapt to technological change or risk being left behind. While innovation was once the domain of large corporations, advancements in digital tools like automation and artificial intelligence are future-proofing SMEs, should they choose to adopt them. That includes the sectors we don't typically associate with cutting-edge innovation: your local salon, the family-run grocer or an independently run café. AI is no longer a futuristic concept reserved for the few, it's part of a broader wave of digital tools that businesses must embrace to stay competitive. We've already seen examples of how adopting new technologies such as AI can make or break businesses. When looking at the booming e-commerce sector, for example, the rise of personalised shopping experiences thanks to artificial intelligence has had a great impact on how retailers are bringing their goods to customers. It is no secret that the popularity of online shopping has led to many businesses leaning on algorithms to present their customers a personalised shop window. Those that have failed to adapt the opportunities AI has created in the space not only lose out on making their offerings more attractive to consumers, but risk losing their business by relying on outdated technology. AI is the new frontier of digital transformation, and organisations that oppose it risk falling behind. Ireland's SMEs in the digital age This digital transformation of SMEs in a plethora of other industries is currently being driven by tools that provide services like automation, AI, and cloud-based systems across Ireland. Once thought to be reserved for larger scale organisations, these technologies are now inexpensive, accessible, and for many, essential to the running of their business day to day. SMEs are the backbone of the Irish economy, representing a third of the country's GVA according to the CSO, and the advantages of embracing digital technologies mentioned above are endless, with some being able to be integrated almost immediately. You don't have to be a tech company to benefit from technology - automation can deliver real value by taking repetitive tasks off the plate of any business. We're increasingly seeing examples like lead qualification for small sales teams or appointment scheduling for local restaurants - freeing up time for business owners to focus on higher-level strategic work. AI, although sometimes seen as removing the human element from processes and procedures, can in fact customise client interactions, improve the sales process, and enable teams to provide a more bespoke experience. Hairdressers for example can use AI scheduling tools to personalise reminders and rebooking prompts. These benefits are especially important for SMEs, which operate with limited resources and where customer care is paramount. The rise of AI According to a recent report conducted by Trinity College Dublin and Microsoft Ireland, AI use in Irish enterprises increased significantly from 49% in 2024 to 91% in 2025. Among the SMEs surveyed, just under 40% of respondents are actively utilising AI, with 10% having adopted an AI strategy. However, there's a noticeable gap when looking at the AI usage in large multinational enterprises. Perhaps in order to gain a competitive edge in an ever-changing and evolving industry, following the example set by larger corporations could be beneficial, improving upon operational efficiency and customer service for example. That being said, there are barriers SMEs face ...

From lab curiosity to commercial reality. Here's what happens when moss meets the brutal economics of bioprocessing.In Part 1, you've heard the science behind moss-based protein production. Now comes the real test: Can it survive the gauntlet of regulatory scrutiny, cost pressures, and manufacturing scale-up that crushes most biotech innovations?In Part 2 of this groundbreaking conversation, David Brühlmann and Andreas Schaaf, Managing Director and CSO of Eleva, dive into the nuts and bolts of what it actually takes to commercialize a revolutionary production platform. Andreas doesn't just theorize—he's lived through 15+ years of transforming Eleva from startup concept to clinical-stage reality, navigating every regulatory hurdle and economic challenge along the way.Three game-changing advantages that caught our attention:Process Robustness That Actually Works: While CHO cells throw tantrums over minor parameter shifts, moss maintains consistent product quality even when your bioprocess isn't behaving perfectly; a lifeline for manufacturing teams dealing with real-world variability.Economics That Make CFOs Smile: Forget expensive viral filtration steps and costly human pathogen testing. Moss's plant heritage eliminates these animal-system burdens, directly impacting your bottom line in ways that matter.Operational Simplicity: Variability in process ingredients and streamlined cell banking contribute to long-term cost and operational efficiencies that compound over time.Andreas shares hard-won insights about what it really takes to challenge entrenched bioprocessing orthodoxy, including the regulatory conversations, the economic realities, and his advice for scientists brave enough to pursue game-changing innovations.Ready to understand how disruptive biotechnology actually makes it from bench to bedside?Connect with Andreas Schaaf:LinkedIn: www.linkedin.com/in/andreas-schaaf-b3797716Website: www.elevabiologics.comNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at www.bruehlmann-consulting.com/call/Support the show

This week, AmSpa President and CSO, Cathy Christensen, speaks with Kendra Bracken-Ferguson, celebrated entrepreneur, founder of BrainTrust and author of The Beauty of Success: Start, Grow and Accelerate Your Brand. They discuss her entrepreneurial journey from building brands to owning in the beauty space, how she evaluates opportunities, and the ways she protects her mental wellness with the help of her community. Listen for: Aligning opportunities with her four pillars: community, mentorship, education, capital; How she knows when it's time to pivot, take a leap or let go of an opportunity; Her nonprofit's efforts for diversity and mentorship in the beauty industry; The importance of building a strong community of trusted partners; Finding joy and managing stress to protect your wellness; Kendra's advice for maintaining positivity in challenging times; Her upcoming ventures in wellness, retail, podcasting and more! Kendra shares more about the power of building your brain trust in her presentation “Community and Counsel: Building Your Brain Trust” on October 4, 2025, at the Women in Aesthetics Leadership Conference. Register to learn why no founder should navigate the path alone and how you can build the counsel you need for sustainable leadership and self-motivation. -- Music by Ghost Score

What if the future of "impossible" protein therapeutics is hiding in your backyard?For decades, CHO cells have ruled the biotech kingdom as the undisputed champions of complex protein production. But here's the uncomfortable truth: countless breakthrough therapies are gathering dust on laboratory shelves—not because the science failed, but because traditional hosts can't produce them.Enter moss. Yes, moss. That humble green organism clinging to rocks and trees might just be the biotech industry's best-kept secret.In this eye-opening episode, David Brühlmann sits down with Andreas Schaaf, Managing Director and CSO of Eleva, who's spent over 20 years turning the "impossible" into reality. Andreas didn't just stumble upon moss; he co-developed Eleva's revolutionary moss-based platform from wild concept to commercial-scale game-changer, propelling the company into clinical trials.Here are three reasons why this episode is worth listening to:Moss as a Game Changer: More than a plant, moss is a higher eukaryote with mammalian-like protein production, including post-translational modifications and human-compatible glycosylation.Overcoming Bioprocessing Barriers: CHO cells are the industry gold standard, especially for monoclonal antibodies. But what about the therapeutic proteins that CHO can't handle? Many promising candidates end up shelved—not because the science isn't sound, but because existing production platforms hit their limits.Bioprocessing, Simplified: Moss grows in standard bioreactors using familiar workflows—just with a whole organism instead of suspended cells.Curious about how plant-based systems could solve your protein production challenges? Dive into this episode to discover how moss could revolutionize your approach to challenging proteins; and let us know about your own production hurdles.Connect with Andreas Schaaf:LinkedIn: www.linkedin.com/in/andreas-schaaf-b3797716Website: www.elevabiologics.comNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at www.bruehlmann-consulting.com/call/Support the show

Now that we are well and truly into summer, its the time of year when businesses all preparing for the influx of visitors far and wide. But despite CSO figures showing a drop in tourism earlier this year, industry experts are expecting a boom of North American visitors this summer.But how is the tourism sector preparing for their busiest time of the year? All to discuss with Lorraine Sweeney Hotelier and business woman and Eoghan O'Mara Walsh, Chief Executive of the Irish Tourism Industry Confederation.The show today was live from Dublin Zoo as part of Newstalk Summer Tour 2025 with thanks to ESB's 1600 EV chargers across Ireland giving you the freedom to go further.

NTNU professor Marit Otterlei nearly threw out the contaminated cell culture where she and her colleagues were testing a new cancer drug.The problem arose on a hot summer day, in Trondheim, in a country not known for hot summer days. So they'd opened the lab's windows overnight.When they came back the next day, they found an uninvited guest, snuggled in with their cancer cell culture: Bacteria!!!Here's the thing, though: although the drug had been designed to work on human cancer cells, it looked like it had killed the bacteria, too!That was remarkable, because the cancer drug targeted a specific mechanism that human cells use to replicate. It looked like the drug also targeted the same mechanism in bacteria -- even though the tree of life had branched away from bacteria 3 BILLION years ago! How could that be?Today's podcast takes a peek into the challenging world of what it takes to bring a drug, especially an antibiotic, to market. But it's also an inside look into how some researchers, with their deep curiosity about the nuts and bolts of how life actually works, can come up with startling discoveries that may someday save our lives. Sometimes, the key to saving lives can be hidden in a protein that hasn't changed much over billions of years.Our guests on today's show are Marit Otterlei, a professor at NTNU's Department of Clinical and Molecular Medicine; Siril Skaret Bakke, innovation manager at NTNU's Technology Transfer Office AS, and Christine Årdal , senior researcher at the Norwegian Institute of Public Health.Marit is a part-time CSO at APIM Therapeutics (https://www.apimtherapeutics.com/), which is developing the cancer drug that she was testing back in 2011, when an open window on a hot summer day led her to suspect that her substance might a possible antibiotic, too. That antibiotic, Betatide, is now undergoing testing that pharmaceutical companies require before investing in it.Here's a list of some of the key academic publications:Gilljam, Karin Margaretha; Feyzi, Emadoldin; Aas, Per Arne; Sousa, Mirta; Müller, Rebekka; Vågbø, Cathrine Broberg. (2009) Identification of a novel, widespread, and functionally important PCNA-binding motif. Journal of Cell BiologyNedal, Aina; Ræder, Synnøve Brandt; Dalhus, Bjørn; Helgesen, Emily; Forstrøm, Rune Johansen; Lindland, Kim. (2020) Peptides containing the PCNA interacting motif APIM bind to the beta-clamp and inhibit bacterial growth and mutagenesis. Nucleic Acids Research (NAR)Nepal, Anala; Ræder, Synnøve Brandt; Søgaard, Caroline Krogh; Haugan, Maria Schei; Otterlei, Marit. (2021) Broad-Spectrum Antibacterial Peptide Kills Extracellular and Intracellular Bacteria Without Affecting Epithelialization. Frontiers in Microbiology Hosted on Acast. See acast.com/privacy for more information.

The CSO has new figures out this week on the rising cost of many basic items in your shopping bags. For more on this Caitriona Redmond is a Consumer expert and food writer with the Irish Examiner and Michael Kilcoyne, is Chairperson of the Consumer Association.

Verdi's Requiem Mass, in its fervent quest for eternal rest, stands as a powerful demonstration of the composer's ability to harness the human voice. Hailed by NPR as “simply magnificent” for their two-time Grammy Award-winning CSO Resound recording of this work, Riccardo Muti and the Chicago Symphony Orchestra and Chorus are joined by a thrilling quartet of international singers to once again deliver a masterful blend of passion and precision. Please note: This program replaces Berlioz's The Damnation of Faust. Learn more: cso.org/performances/24-25/cso-classical/muti-verdi-requiem

Patrick Nielander has spent nearly 40 years in the field of Law Enforcement.  Seven years of Federal Court experience (CSO, Special Deputy US Marshal) and five years as the District Supervisor (CSO Program, JSD7/SIN, District 28).   Served as the Assistant Section Commander for the Medical Department of the Marion County Jail, Indianapolis, Indiana. Responsible for over 3,000 inmates.   Have acquired police patrol experience, correctional healthcare experience, and business management experience.   Previously a Law Enforcement Officer (Sgt., Retired) at the Indianapolis Metropolitan Police Department • Marion County Sheriff's Department (Merged Police Departments) and Indianapolis International Airport (Sgt.)   Have held the position of Assistant Branch Manager for Airport Security serving a national security company at the Indianapolis International Airport. Served as adjunct faculty in the criminal justice program of a national university.  His father and Uncle Gary have been elders in the United Church of God, with whom I have become well-acquainted in my ministry.   We discuss thought-provoking issues about living in and being responsible in an unjust world.  

10 per cent of Irish households have a net wealth of more than €1 million while the bottom 10 per cent are worth less than €2,400, according to new figures from Central Statistics Office. Ian Guider, columnist with the Business Post, joins The Last Word to discuss this CSO data and more of the latest business news. Catch the full chat by pressing the 'Play' button on this page!

First-party data can only take you so far. To scale your healthcare marketing strategy and reach high-intent patients, you need to tap into third-party audiences. Cardinal's CGO, Lauren Leone, and CSO, Rich Briddock, break down how to use third-party data to improve targeting, reach clinical and payer-based segments, and overcome data limitations.The discussion also covers the costs and platforms for activating these audiences, providing you with a comprehensive understanding of how to integrate them into your marketing strategy to improve lead quality and operational efficiency. RELATED RESOURCES Reaching the Right Patients with 3P Data - https://www.cardinaldigitalmarketing.com/healthcare-resources/podcast/reaching-right-patients-with-3p-data/ How Meta's Data Restrictions Impact Healthcare Advertising Strategies - https://www.cardinaldigitalmarketing.com/healthcare-resources/blog/meta-announces-major-changes-healthcare-advertising/ 10 Ways to Succeed on Meta in 2025 - https://www.cardinaldigitalmarketing.com/healthcare-resources/blog/10-ways-to-succeed-on-meta-in-2025/ 5-Step Paid Media Strategy to Attract Your Ideal Patients - https://www.cardinaldigitalmarketing.com/healthcare-resources/blog/paid-media-patient-acquisition-guide/#)-implement-advanced

Esteban Batallán, the CSO's principal trumpet since 2019, makes his much-anticipated debut as a soloist with the Orchestra in a pair of brilliant, high-flying concertos. Riccardo Muti frames the program with Joseph Haydn's tempestuous Symphony No. 48 and Schubert's Haydn-inspired Tragic Symphony. Learn more: cso.org/performances/24-25/cso-classical/muti-and-esteban-batallan

Sandy Carter, COO and Head of GTM at Unstoppable Domains, discusses the potential of on-chain and digitized identities, including real-world examples that highlight shortcomings of current systems. She also reveals details of the new .BRAVE domain and its significance for the Brave community. Key Takeaways:  How Unstoppable domains allows users to store verified digital identity information securely The convergence of AI and blockchain technology, including the potential of AI agents within crypto wallets The launch of the new.BRAVE domain and why this is such an exciting announcement for the Brave community Guest Bio: Sandy Carter is a globally recognized expert and innovator in AI and blockchain, having led groundbreaking advancements in AI and blockchain. Currently, as COO of Unstoppable Domains—a leading digital identity platform—she is revolutionizing how users manage and own their online identities. Formerly COO, CPO, and CSO at AWS and IBM, Sandy has successfully driven billions in revenue growth and spearheaded transformative technology adoption at scale. Sandy is author of the bestselling book “AI First, Human Always”, and has been recognized as a Microsoft MSN Top 10 AI Entrepreneur. She has been featured in Adweek's AI Power 100, and honored by Constellation Research as a Top AI Business Leader. She has delivered keynote addresses at global forums such as CES, SXSW, Davos, and more, and has been consistently rated among the top speakers. An accomplished global speaker, she has captivated audiences of up to 50,000 attendees in over 89 countries (and has proudly sampled McDonald's in each one). ---------------------------------------------------------------------------------------- About this Show: The Brave Technologist is here to shed light on the opportunities and challenges of emerging tech. To make it digestible, less scary, and more approachable for all! Join us as we embark on a mission to demystify artificial intelligence, challenge the status quo, and empower everyday people to embrace the digital revolution. Whether you're a tech enthusiast, a curious mind, or an industry professional, this podcast invites you to join the conversation and explore the future of AI together. The Brave Technologist Podcast is hosted by Luke Mulks, VP Business Operations at Brave Software—makers of the privacy-respecting Brave browser and Search engine, and now powering AI everywhere with the Brave Search API. Music by: Ari Dvorin Produced by: Sam Laliberte  

2024 Ravinia Festival Opening Night: Celebration of Americana - Broadcast by CSO Association

Comparing and contrasting “The Prince of Egypt” by Dreamworks Animation with scriptures from The Torah, The Holy Bible, and the Qur'an.  This podcast contains certain copyrighted works that were not specifically authorized to be used by the copyright holder(s), but which we believe in good faith are protected by federal law and the fair use doctrine (Section […] The post CSO 19b – The Prince of Egypt Part 2 first appeared on Cinema Story Origins Podcast.

In this On Location episode during OWASP AppSec Global 2025 in Barcelona, Sarah-Jane Madden brings a unique lens to application security, shaped by her journey from developer to security leader and CSO. Speaking at OWASP AppSec Global, she tackles one of today's most pressing concerns: how AI is reshaping software engineering—and how we must respond without compromising core values like quality and security.Madden emphasizes that AI is only the latest in a series of major disruptions, comparing it to shifts like remote work triggered by COVID. Her message is clear: organizations must prepare for continuous change, not just chase the current trend. That means prioritizing adaptability and ensuring critical practices like application security are not sacrificed in the rush to speed up delivery.She makes the case for a layered, iterative approach to development—rejecting the outdated linear mindset. Developers, she argues, should leverage AI as an accelerator, not a replacement. Think of AI as your digital intern: handling the drudgery, automating boilerplate code, and even applying internal security standards to code before it reaches human hands. This frees developers to focus on creative problem-solving and thoughtful architecture.However, Madden cautions against blind enthusiasm. While experimentation is healthy, organizations must be discerning about outcomes. Speed is meaningless without quality, and quality includes security. She calls on developers to advocate for high standards and reminds business leaders not to fall for the allure of shortcut statistics or flashy claims that promise results without skilled labor. Her analogy of microwave dinners vs. proper cuisine illustrates the risk of prioritizing convenience over substance—especially in complex problem-solving environments.For line-of-business leaders, Madden urges realistic expectations. AI can enhance productivity, but it doesn't eliminate the need for thoughtful development. Ultimately, customers will notice if quality drops, and reputational damage is hard to undo.In closing, Madden celebrates OWASP as more than an organization—it's a source of support, camaraderie, and genuine community for those working to build secure, reliable systems. Her message? Embrace change, use tools wisely, protect your standards, and never forget the human side of engineering.GUEST: Sarah-Jane Madden | Global Director of Cyber Defense at Fortive | https://www.linkedin.com/in/sarahjanemadden/HOST: Sean Martin, Co-Founder at ITSPmagazine and Host of Redefining CyberSecurity Podcast | https://www.seanmartin.comSPONSORSManicode Security: https://itspm.ag/manicode-security-7q8iRESOURCESLearn more and catch more stories from OWASP AppSec Global 2025 Barcelona coverage: https://www.itspmagazine.com/owasp-global-appsec-barcelona-2025-application-security-event-coverage-in-catalunya-spainCatch all of our event coverage: https://www.itspmagazine.com/technology-and-cybersecurity-conference-coverageWant to tell your Brand Story Briefing as part of our event coverage? Learn More

Comparing and contrasting “The Prince of Egypt” by Dreamworks Animation with scriptures from The Torah, The Holy Bible, and the Qur'an.  This podcast contains certain copyrighted works that were not specifically authorized to be used by the copyright holder(s), but which we believe in good faith are protected by federal law and the fair use doctrine (Section […] The post CSO 19a – The Prince of Egypt Part 1 first appeared on Cinema Story Origins Podcast.

In Randall Goosby, the pioneering American composer Florence Price “has her ideal champion,” writes The Guardian, “his playing full of old-school warmth and breadth but never schmaltzy.” Price's beguiling violin concerto shares a program with Prokofiev's enchanting Seventh Symphony, composed for a children's radio broadcast. The suite from Die Meistersinger von Nürnberg gathers stirring moments from Wagner's opera. Learn more: cso.org/performances/24-25/cso-classical/elder-goosby-and-price

Debra Freitas, CEO of Light Source Communications (LSC), and Pete Empie, CSO and President of LSC, join JSA TV live from PTC'25 in Honolulu to recap 2024 and discuss the company's progress on its dark fiber networks in Phoenix and Tulsa, as well as new additions to LSC's executive leadership team, AI connectivity and more. #PTC'25

Dvořák's radiant salute to the New World kicks off an American road trip with James Gaffigan at the wheel. Take in poignant selections from Gershwin's landmark opera — sung by Janai Brugger — and the composer's urbane and nostalgic love letter to Paris. Chicago native Florence Price sets two American poems to song, and a pair of symphonic showstoppers by Bernstein transports audiences to “New York, New York” and beyond. Learn more: cso.org/performances/24-25/cso-classical/an-american-suite

Haitink Conducts Mahler 2 - Broadcast by CSO Association

What drives a 41-year-old husband, father of three, and CSO of a $300M brand to willingly get punched in the face—on purpose?In this raw and riveting episode of Live Life by Design, Jeff Mendez sits down with Dan Gardner, Chief Sales Officer of Bucked Up, to unpack his decision to enter a professional bare knuckle boxing match. From the blood, stitches, and mental battles to the business lessons and parenting insights, Dan shares why this fight wasn't about victory in the ring—but triumph over complacency.This one's about showing up for your goals, leading by example, and becoming your best self—even when it hurts.This episode is a masterclass in mindset, legacy, and leading with action.Timestamps:00:00 - Intro & Dan's fight aftermath01:30 - Why bare knuckle boxing at 41?06:24 - Training, diet, and mental prep10:22 - Doers vs critics mindset14:12 - Bucked Up's $300M growth story23:14 - Will Dan fight again?29:15 - Mental battles & defining moments34:04 - Becoming a better father and leader38:26 - Sales mindset & hospital bed closing story44:12 - Final advice on excuses & legacy Hosted on Acast. See acast.com/privacy for more information.

Trident Room Podcast lead host U.S. Navy Cmdr. Alanna Youngblood interviews Cmdr. Matthew Morris and Lt. Cortni Thrasher about their unique experiences while working to complete their theses. Cmdr. Morris first discusses how he, along with his thesis partners, designed experimentation to test previous theories of how to transmit the most important information to units in a denied environment. Lt. Thrasher then speaks about her thesis, which is in direct coordination with U.S. Pacific Fleet objectives and a topic from the Nimitz Research Group, studying how the incorporation of amphibious aircraft can benefit military operations in the Pacific. Cmdr. Matthew Morris graduated from Dickinson College in 2008 with a BA in German and commissioned through OCS as a SWO in 2009, transferring to Information Professional in 2014. He earned an MS in Network Operations at NPS and is an IW WTI in Command and Control/Cyber Operations. His tours include COMM-O onboard USS LASSEN, OPS and NAV for PCC Hotel, ISO and Staff NAV for COMDESRON 9, Flag COMM-O for CSG-9. He is currently serving as the CSO onboard USS GEORGE WASHINGTON. Lt. Cortni Thrasher is an Aerospace Maintenance Duty Officer in the U.S. Navy. She was previously enlisted as an aviation electronics technician after graduation in 2012 with a BS. She worked on Prowlers and Growlers with a deployment on USS STENNIS before transitioning to the AMDO community in 2019 and commissioning through OCS. She then served as a part of VFA 94 in Lamoore, CA as their maintenance material control officer. While there she deployed on the USS NIMITZ for a COVID deployment in 2020 and is now a graduate of the Naval Postgraduate School.

Join Kamyabi Network: https://kamyabinetwork.com/Guest Introduction: Joining us today is Shayan Shabir, the Founder and CEO of Strategic Pulse, a company helping businesses grow using AI, cybersecurity, and digital tools. Shayan has over 20 years of experience working across the UK, Australia, and South Asia.Before this, he was the CIO and CSO at Nova Systems, where he led a $35 million digital transformation and built a $7 million cybersecurity program. He has worked in defence, energy, and healthcare, and handled many real cyber attacks in his career.Shayan is certified in CISM, CRISC, and CDPSE, and is focused on helping businesses become faster, safer, and more future-ready.Do not forget to subscribe and press the bell icon to catch on to some amazing conversations coming your way!Socials:TBT's Official Instagram: https://www.instagram.com/thoughtbehindthings Muzamil's Instagram: https://www.instagram.com/muzamilhasan Muzamil's LinkedIn: https://www.linkedin.com/in/muzamilhasan Shahyan's LinkedIn: https://www.linkedin.com/in/shahyan-s-6994261a3/Podcast Links:Spotify: https://spoti.fi/3z1cE7F Google Podcast: https://bit.ly/2S84VEd Apple Podcast: https://apple.co/3cgIkf

Comparing and contrasting Dreamworks SKG's “The Prince of Egypt” with the original scriptures fond in The Torah, The Christian Bible, and the Qur'an.  This podcast contains certain copyrighted works that were not specifically authorized to be used by the copyright holder(s), but which we believe in good faith are protected by federal law and the fair […] The post CSO 019a – The Prince of Egypt Part 1 first appeared on Cinema Story Origins Podcast.